Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 10, 2026

Xponential Fitness (XPOF): +26% Surge in 30 Days Amid Strategic Review Buzz

Key Takeaways

  • XPOF stock surged +26% over the past 30 days, driven primarily by the April 6 announcement of a strategic alternatives review, including potential sale or merger, sparking investor optimism.
  • Over the past quarter, shares declined -9%, pressured by a sharp drop following Q4 2025 earnings miss in late February and conservative 2026 guidance.
  • Key catalysts include activist investor pressure for strategic review, FTC settlement resolution, and analyst actions amid ongoing franchisee challenges.
  • Macro fitness sector recovery and portfolio optimization efforts support recent rebound, though earnings volatility remains a concern.
  • Stock exhibits high volatility, with range-bound trading post-earnings before recent breakout.

Understanding Xponential Fitness (XPOF) and Its Place in the Market

Xponential Fitness, Inc. (XPOF) stands out as a leading global franchisor of boutique health and wellness brands, such as Club Pilates, StretchLab, YogaSix, Pure Barre, and BFT. The company's business model centers on franchise royalties, fees, and equipment sales or leases to studio operators, which generates revenue without the burden of direct operational costs from owning studios. In the competitive leisure and fitness industry, XPOF maintains a strong position as the largest U.S. Pilates franchisor and among the top barre and yoga franchisors by studio count. This asset-light approach offers scalability, but it also leaves the company exposed to franchisee performance, regulatory scrutiny, and shifts in consumer demand—elements that have played a significant role in recent stock movements during post-pandemic recovery and economic pressures on discretionary spending.

XPOF Stock Performance: 30-Day Rally vs. Quarterly Decline

In the last 30 days, XPOF stock climbed +26%, moving from about $6.03 to $7.58, reflecting a trend-driven recovery with gains picking up steam in early April. The action was volatile but directional, as shares broke out from a $5.50-$6.30 range on higher volume.

Looking back over the past quarter, however, shares dropped -9%, sliding from roughly $8.31 to $7.58. This period featured steep declines after earnings, followed by consolidation near the lows before the recent upswing, highlighting broader headwinds partially countered by emerging positives.

Key Drivers Behind XPOF's Recent 30-Day Gain

From what I see, the main driver was XPOF's April 6 announcement that its board has started a formal review of strategic alternatives, which could include a sale, merger, or other transactions, with advice from Jefferies LLC. This came on the heels of pressure from activist investor Kanen Wealth Management on April 1, pushing for a sale and sparking speculation that lifted shares more than 20% in the days that followed. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against peers, and analyst moves like Roth/MKM raising its price target further bolstered sentiment. The March 18 resolution of the FTC settlement removed a notable overhang, while improving fitness sector demand provided tailwinds. Together, these shifted views from cautious to optimistic, powering the surge.

What Shaped XPOF's Performance Over the Past Quarter

The -9% quarterly drop traced back to the February 26 earnings release, where Q4 2025 revenue came in flat at $83 million—beating estimates—but adjusted EPS posted a loss of -$0.91, far missing the expected -$0.03. Full-year 2025 revenue fell 2%, and 2026 guidance looked conservative at $260-270 million in revenue. Shares cratered nearly 50% from $8.05 to $4.26 on the miss and FTC news. A March 19 downgrade from Raymond James to Market Perform, pointing to Club Pilates softness, piled on the pressure. Broader issues like inflation curbing consumer fitness spending, plus franchisee litigation and regulatory hurdles, added weight. Institutional selling and a shift away from cyclicals exacerbated the slide, though things stabilized ahead of April's rally.

Discovering Effective Tools with Tickeron’s Trending AI Robots

In my own research and trading, I often turn to Tickeron’s Trending AI Robots to identify top performers among hundreds of AI trading bots that scan and trade thousands of tickers across markets. These bots use varied strategies—like trend-following, mean reversion, or momentum—across short-term, swing, or long-term horizons, with clear metrics on win rates, profit factors, and drawdowns. Updated live based on fresh results and market relevance, the page spotlights those thriving in today's conditions, giving practical insights into automated trading. I find it valuable for sharpening analysis and spotting opportunities beyond manual reviews.

What to Watch in XPOF's Outlook Moving Forward

One thing that stands out is the need to track the strategic alternatives review closely, including any bids or results. Q1 2026 earnings, likely around May 7, will offer clarity on revenue guidance, adjusted EBITDA, and net studio growth. I'm watching franchisee metrics, particularly for Club Pilates, as portfolio tweaks continue. Broader trends in consumer spending, interest rates, and fitness demand recovery will matter too. Regulatory wrap-ups, M&A possibilities, analyst updates, and shifts in institutional ownership could move the needle, while risks like more earnings shortfalls or a drawn-out process linger.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: XPOF

Momentum Indicator for XPOF turns negative, indicating new downward trend

XPOF saw its Momentum Indicator move below the 0 level on September 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 74 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for XPOF turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 34 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XPOF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for XPOF entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where XPOF advanced for three days, in 243 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

XPOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. XPOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XPOF's P/B Ratio (434.783) is very high in comparison to the industry average of (21.458). P/E Ratio (26.609) is within average values for comparable stocks, (43.398). XPOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.389). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (0.489) is also within normal values, averaging (5.558).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XPOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are YETI Holdings (NYSE:YETI), Peloton Interactive (NASDAQ:PTON).

Industry description

The Leisure and Recreation Products industry includes companies offering recreational goods/services such as video games, swimming pools, golf courses, boats, outdoor spaces etc. Since these are mainly geared towards consumers, strong employment conditions and healthy incomes generally augur well for the recreational products industry. Some of the largest market caps in this space belong to video game developers (e.g. Activision Blizzard, Electronic Arts and Take-two Interactive), and toy /board game makers (like Hasbro).

Market Cap

The average market capitalization across the Recreational Products Industry is 2.19B. The market cap for tickers in the group ranges from 932 to 31.87B. OLCLY holds the highest valuation in this group at 31.87B. The lowest valued company is CMOT at 932.

High and low price notable news

The average weekly price growth across all stocks in the Recreational Products Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -3%. KMRK experienced the highest price growth at 12%, while XPOF experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Recreational Products Industry was 147%. For the same stocks of the Industry, the average monthly volume growth was 141% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 62
Price Growth Rating: 64
SMR Rating: 69
Profit Risk Rating: 94
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
XPOF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry RecreationalProducts

Profile
Details
Industry
N/A
Address
17877 Von Karman Avenue
Phone
+1 949 346-3000
Employees
358
Web
https://www.xponential.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.